期刊文献+

原发韦氏环非霍奇金淋巴瘤的CT诊断 被引量:1

在线阅读 下载PDF
导出
摘要 原发于头颈部的结外淋巴瘤中,约有一半以上发生于韦氏环。在美国,所有淋巴瘤中,发生于韦氏环的约占5%~10%,占所有结外淋巴瘤的1/3,影像诊断尤其是CT扫描,往往是患者在临床进行的首诊项目,所以,提高CT对原发韦氏环非霍奇金淋巴瘤(Non-hodgkin's lymphoma,NHL)的 认识至关重要。现对我院2003—2008年诊治的原发韦氏环NHL病例进行回顾性分析,
出处 《重庆医科大学学报》 CAS CSCD 2008年第10期1278-1279,共2页 Journal of Chongqing Medical University
作者简介 李晓阳(1966-),男,副主任医师。研究方向:肿瘤的影像诊断和介入治疗
  • 相关文献

参考文献8

  • 1Jacobs C,Hoope RT.Non-hodgkin's of the head and neck extranodal sites[J]. Int J Radiat Oncol Biol Phys, 1985,11:357-364.
  • 2Jacobs C,Weiss L,Hoope RT. The managmengt of extranodal head and neck lymphomas.Arch Otolaryngol Head Neck Surg[J]. 1986,112 : 654-658.
  • 3Hoope RT,Burke JS,Glastein E,et al. Non-hodgkin's lymphoma: involvemengt of the Waldeyer's ring[J]. Cancer, 1978,42: 1096-1104.
  • 4Saul SH,Kapadia SB.Primary lymphoma of Waldeyer's ring. Clinicopathologic study of 68 cases[J]. Cancer.1985,56:157-166.
  • 5Aviles A,Diaz-Maqueo JC,Rodriguez L,et al. Group-risk Non- hodgkin' s lymphoma[J].Arch Invest Med, 1990,22:11-16.
  • 6李晔雄,高远红,袁智勇,赵路军,刘新帆,余子豪.国际预后指数在韦氏环非霍奇金淋巴瘤的预后意义[J].中华放射肿瘤学杂志,2002,11(2):105-110. 被引量:34
  • 7Aviles A, Delgado S, Ruiz H, et al.Trentment of Non-hodgkin' s lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy t [J]. Oral Oncol,Eur J Cancer, 1996,32B: 19-32.
  • 8李晓阳,苑杰,钟洪波,李骥,陈旭荣,李会菊,马巨文,张建华,张德江,赵林,胡文俭.MRI对鼻咽癌、颅底转移及放疗中、后改变的诊断与评价[J].CT理论与应用研究(中英文),2005,14(1):47-51. 被引量:4

二级参考文献3

  • 1高元桂 蔡幼铨 蔡祖龙.磁共振成像诊断学[M].北京:人民军医出版社,2002.161-163.
  • 2吴恩惠.中华影像医学[M].北京:人民卫生出版社,2002.80-85.
  • 3顾仲义,顾本惠,姚玉珍,孟婉珍,黄克伟,朱向帜.Ⅱ期咽淋巴环非霍奇金淋巴瘤治疗探讨[J].中华放射肿瘤学杂志,1998,7(3):138-141. 被引量:12

共引文献36

同被引文献8

  • 1KOJIMA M, NAKAMURA N, ITOH H, et al. Ep- stein-Barr virus-related atypical lymphoproliferative disorders in Waldeyer's ring : a clinicopathological stud- y of 9 cases[J]. Pathobiology, 2010,77 218-- 224.
  • 2VOSE J, ARMITAGE J, WEISENBURGER D, et al. International peripheral T-cell and natural killer/T- cell lymphoma study: pathology findings and clinical outcomes[J]. J Clin Oncol, 2008,26 : 4124 - 4130.
  • 3ARKENAU H T, CHONG G,CUNNINGHAM D, et al. Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lym- phoma:the Royal Marsden Hospital experience[J]. Haematologica, 2007,92 : 271 -- 272.
  • 4ZINZANI P L, VENTURINI F, STEFONI V, et al. Gemcitabine as single agent in pretreated T-cell lym- phoma patients:evaluation of the long-term outcome [J]. Ann Oneol, 2010,21 : 860 -- 863.
  • 5MAHADEVAN D,UNGER J M,SPIER C M,et al. Phase 2 trial of combined cisplatin, etoposide, gemcit- abine,and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350[J]. Cancer,2013,119:371--379.
  • 6LE GOUILL S,MILPIED N,BUZYN A,et al. Graft- versus-lymphoma effect for aggressive T-cell lympho- mas in adults: a study by the Socitfi Francaise de Greffe de Mo;lle et de Thrapie Cellulaire[J]. J Clin Oncol, 2008,26 : 2264 -- 2271.
  • 7DANG N H, PRO B, HAGEMEISTER F B, et al. Phase II trial of denileukin diftitox for relapsed/refrac tory T-cell non-Hodgkin's lymphoma[J]. Br J Haema tol, 2007,136 : 439-- 447.
  • 8CYCONNOR O A,PRO B,PINTER-BROWN L,et al. Pralatrexate in patients with relapsed or refractory pe- ripheral T-cell lymphoma., results from the pivotal PROPELstudy[J]. J Clin Oncol, 2011,29:1182-- 1189.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部